AGREEMENT AND PLAN OF MERGERMerger Agreement • October 4th, 2017 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • California
Terms Cross Reference in Agreement (if not otherwise defined in Article I) Acquisition Transaction Section 6.1(a) Adjusted Milestone Payment Amount Section 2.9(d)(iv) Adjusted Net Closing Cash True-Up Amount Section 2.12(e)(ii) Adjusted Revenue Sharing Amount Section 2.9(d)(iv) Agreement Preamble Agreement of Merger Section 2.1(b) Antibody Section 2.9(a)(i) Appraiser Section 2.12(d)(ii) Balance Sheet Date Section 3.4 Certificates Section 2.8(b) Claim Notice Section 8.6(a) Closing Section 2.2 Closing Date Section 2.2 Closing Notice Section 2.12(a)(i) Company Preamble Company 401(k) Plans Section 6.5 Company Balance Sheet Section 3.4 Company Chicken Section 2.9(a)(vi) Company Disclosure Letter Article III Company Indemnified Party Section 6.13(a)
